Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer

Recommendation ID: IPG532/1
Question: NICE encourages further research into low-energy contact X-ray brachytherapy (CXB) for early-stage rectal cancer. Research should clearly describe details of patient selection and treatment intent. It should document adjunctive treatments and subsequent procedures. Outcomes should include local recurrence, survival, disease-free survival and quality of life. NICE may update the guidance on publication of further evidence.
Any explanatory notes (if applicable): In patients for whom surgery is not considered suitable, current evidence on the efficacy and safety of low-energy contact X-ray brachytherapy (CXB; the Papillon technique) for early-stage rectal cancer is adequate to support the use of this procedure, provided that normal arrangements are in place for clinical governance, consent and audit.

Source guidance details

Comes from guidance: Low energy contact X-ray brachytherapy (the Papillon technique) for early stage rectal cancer
Number: IPG532
Date issued: September 2015

Is this a recommendation for the use of a technology only in the context of research?	No
Is it a recommendation that suggests collection of data or the establishment of a register?	No